Editorial Staff

Amar Sawhney on Sikhs, STEM & COVID

/in , , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

The entrepreneurial spirit among immigrants and refugees allows them the flexibility to pursue unexpected courses of action, adapt, accept risk and make the most of opportunities they didn’t even know of before. For Dr. Amar Sawhney from India, that started at the University of Texas at Austin with 30 job rejections out of 30 applications. But he charted a path that would see him go in directions hitherto unknown to him: getting a PhD, helping found a company, journeying to Boston, and starting a string of new companies, using his chemical engineering background to save lives through remarkable local therapy innovations. To date, he has founded eight companies accounting for 4,000 jobs and more than $2 billion in revenue. He’s been named a “Champion of Change” by The White House, one of the “five most innovative Medical Device CEOs” by MassDevice, the EY regional entrepreneur of the year, The Immigrant Learning Center’s own Immigrant Entrepreneur Awardee for Life Science Business. But his influence extends well beyond that space into environmental conservationism, safeguarding refugees, mentoring and promoting STEM education, and building public understanding of America’s Sikhs, as you’ll hear in this week’s episode of JobMakers.

Guest:

Amarpreet Sawhney, Ph.D., is the Chairman and CEO OF Instylla Inc which is developing new liquid embolics for tumor embolization and hemostasis. He is also CEO of Rejoni Inc., which is developing products to prevent adhesions following gynecological interventions. Previously he was President and CEO of Ocular Therapeutix, Inc. (OCUL: NASDAQ) a company focused on unmet needs in ophthalmic drug delivery. He was also the Chairman of Augmenix, Inc. (acquired by Boston Scientific), Founder and CEO of Confluent Surgical (acquired by Covidien), the Chairman of MarketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence, technology founder of Focal, Inc. (acquired by Genzyme) and Access Closure Inc. (acquired by Cardinal Health). He holds over 120 patents, which form the basis for several first-of-a-kind medical devices that have helped over 5 million patients worldwide. He has founded eight companies, which account for over 4,000 jobs created and over $2 billion in revenue to date. Dr. Sawhney helps foster entrepreneurship by mentoring young innovators and creating companies through Incept, a medical device incubator. He is a member of the board of directors of EcoSikh, Axtria, Imperative care, Instylla, Rejoni, Tulavi, and Incept LLC. He is on the advisory board of the MIT museum. Dr. Sawhney is passionate about education, wildlife, and environmental causes, which he is involved in supporting through his family foundation. Dr. Sawhney has been recognized by several awards including being named the “Champions of Change” and “Outstanding American by Choice” awards by the Whitehouse, “Five most innovative Medical Device CEOs” by MassDevice, MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, the E&Y regional entrepreneur of the year award, Mass High Tech All Star award, TiE Star award, the University of Texas Outstanding Young Engineering Graduate award, and the Indian Institute of Technology Delhi Distinguished Alumni award. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.

Get new episodes of JobMakers in your inbox!

Browse recent episodes of Pioneer podcasts:

Pulitzer Prize-Winning Prof. David Hackett Fischer on Paul Revere, George Washington, & American Independence

This week on “The Learning Curve," co-hosts Gerard Robinson and Cara Candal talk with David Hackett Fischer, University Professor and Earl Warren Professor of History Emeritus at Brandeis University, and the author of numerous books, including Paul Revere's Ride and the Pulitzer Prize-winning Washington's Crossing. As America prepares to celebrate the Fourth of July, they review key figures who helped secure independence from Great Britain, including Paul Revere, immortalized in Longfellow’s classic poem, and Founding Father George Washington, known among his contemporaries as the “indispensable man” of the revolutionary cause.

Semyon Dukach on the High Value of Immigrants for the U.S. Economy

This week on JobMakers, Host Denzil Mohammed talks with Russian-born entrepreneur Semyon Dukach about the high value of immigrants to the U.S. Dukach started a seed stage fund for immigrant tech founders, One Way Ventures, in response to the early restrictive moves of the Trump administration, particularly the Muslim ban. 

Renters’ Unsung Heroes: Small Landlords Endure Without Income or Relief

Hubwonk host Joe Selvaggi talks with MassLandlords’ Doug Quattrochi about ways landlords faced the challenges of being caught between tenants unable to pay rent during COVID-19 shutdown and having little or no programmatic relief from state and federal agencies.

Jo Napolitano on the Inspiring Stories of Immigrant Children

This week on JobMakers, Host Denzil Mohammed talks with Jo Napolitano, journalist, former Spencer Fellow at Columbia University, and author of the new book, The School I Deserve: Six Young Refugees and Their Fight for Equality in America, about the enterprising spirit of immigrants and refugees across the nation and at the U.S.-Mexico border.

AEI’s Naomi Schaefer Riley on Parenting, Excessive Screen Time, & Religion in American Education

0 Comments
/
This week on “The Learning Curve," Gerard Robinson and guest co-host Kerry McDonald talk with Naomi Schaefer Riley, a resident fellow at the American Enterprise Institute and author of several books, including Be the Parent, Please.

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute's Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Umesh Bhuju Seeks a Fair Deal for Immigrants, Farmers & the Environment

This week on JobMakers, Host Denzil Mohammed talks with Umesh Bhuju, owner of Zumi’s Espresso in Ipswich, Massachusetts, about how a business model based on selling nothing but fair-trade products can thrive in a world driven by profit. He describes his early experiences in his homeland of Nepal, where he witnessed child labor, and how that has shaped his pursuit of the American dream.

New York Times Best Seller Paul Reid on Winston Churchill, WWII, & the Cold War

This week on “The Learning Curve," Cara and guest co-host Kerry McDonald talk with Paul Reid, co-author, with William Manchester, of the New York Times best-selling biography of Winston Churchill, The Last Lion: Defender of the Realm, 1940-1965. Reid shares how he was enlisted to complete William Manchester’s biographical trilogy on the greatest political figure of the 20th century, which became a best-seller.

Unintended Tax Consequences: Modeling the Effects of the Millionaire’s Tax on Massachusetts’ Economic Future

0 Comments
/
Hubwonk host Joe Selvaggi talks with Beacon Hill Institute President Dr. David Tuerck about his recent analysis of the proposed 4% surtax on incomes over $1 million in Massachusetts, and his estimate of the number of individuals who will leave the state as a result. Tuerck, an economist, used STAMP modeling tools comparing the static projections offered by proponents of the so-called "Fair Share Amendment" with a model simulation that accounts for the unintended effects of the tax.

Dr. Babak Movassaghi on Winning in Football & Healthcare Innovation

0 Comments
/
This week on JobMakers, Host Denzil Mohammed talks with Dr. Babak Movassaghi, founder of InfiniteMD (acquired last summer by ConsumerMedical), which connects patients with top U.S. medical professionals through second-opinion video consultations, guiding patients to better care. When the world shut down due to COVID-19, Dr. Movassaghi's company was already prepared to serve patients via telehealth. In this episode, they discuss his fascinating pivot from physics and professional football in Germany, to healthcare and innovation here in the U.S., an extension of his ability to navigate multiple identities as an Iranian-German living the American Dream.

Nina Rees on the 30th Anniversary of Charter Public Schools in America

This week on “The Learning Curve," Gerard and Cara celebrate the 30th anniversary of charter schools with Nina Rees, President and Chief Executive Officer of the National Alliance for Public Charter Schools.

Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?

Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.